Core Insights - Nuo Wei Biotechnology (Wuxi) Co., Ltd. has recently completed a B+ round of financing, raising several tens of millions of RMB, with investors including Tianjin Botong Venture Capital and Xichuang Investment [1] Company Overview - Nuo Wei Biotechnology was established in 2023 and is located in Wuxi City, focusing primarily on research and experimental development [1] - The company has a registered capital of 15.09968216 million RMB and has completed its B+ round financing by 2025, with the transaction amount being several tens of millions of RMB [1] Investment and Intellectual Property - Nuo Wei Biotechnology has made investments in 2 external companies and holds 12 patent registrations [1] - The company possesses 2 administrative licenses [1] Shareholders - The shareholders of Nuo Wei Biotechnology include Wang Xiaofang, Beijing Nuo Wei Biotechnology Partnership (Limited Partnership), Beijing Guoxin Haixiang Equity Investment Partnership (Limited Partnership), Beijing Nuo Wei Technology Development Partnership (Limited Partnership), and Beijing Xingzhiyuan Technology Partnership (Limited Partnership) [1]
诺未生物技术（无锡）有限公司获“B+轮”融资，金额数千万人民币
Sou Hu Cai Jing·2025-07-30 02:23